secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2023-08-09T23:59:59+00:00
Accession:  0000950170-23-040033
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q2 revenue up 24% to $259.6M; raises FY revenue guidance to $1.01-1.04B
--------------------------------------------------------------------------------

- Q2 revenue $259.6M (+24% YoY); net loss $45.5M improved from $68.7M loss.
- Adjusted EBITDA $14.1M (-3% YoY); Center Margin $73.0M (28.1% of revenue).
- Total clinicians 6,132 (+17% YoY); net add 171 in Q2.
- FY 2023 revenue guidance raised to $1.01-1.04B; reaffirms Adj. EBITDA $50-62M.
- Q3 2023 guidance: revenue $250-260M, Adj. EBITDA $11-17M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017023040033/0000950170-23-040033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017023040033/lfst-20230809.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-040033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer